Akèy › Atrofi Bulbospinal Lyen ak X
Etid klinik pou Atrofi Bulbospinal Lyen ak X ap rekrite nan Etazini
6 etid pou Atrofi Bulbospinal Lyen ak X ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 29, 2026 · NCT07190300A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07723248Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 8 a 99 · Tout sèks · Mizajou Aug 13, 2026 · NCT04708431Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Gason · Mizajou Aug 13, 2026 · NCT04944940ALS/MND Natural History Study Data Repository
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou May 20, 2026 · NCT05966038Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 29, 2025 · NCT01793168Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.